Products

QP-Breast® is an advanced AI-driven software solution developed by Quibim to enhance the interpretation of breast MRI scans. By analyzing MRI sequences, QP-Breast® assists in lesion characterization, identifying disease subtypes, and correlating imaging features with patient outcomes. This integration of imaging data with molecular biology information empowers oncologists to tailor treatment plans more effectively, leading to personalized and precise patient care.

QP-Lung® is an advanced AI-driven solution designed to enhance the analysis of lung cancer heterogeneity and predict clinical outcomes using standard-of-care (SoC) CT scans. By integrating with existing diagnostic techniques, QP-Lung® classifies tumor mutational status, forecasts responses to immune checkpoint inhibitors, and estimates overall survival rates from baseline CT images.

BioXcel Therapeutics is a biopharmaceutical company leveraging artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology. Their lead product, IGALMI™ (dexmedetomidine) sublingual film, is approved for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. Additionally, BioXcel is investigating BXCL501, an orally dissolving film formulation of dexmedetomidine, for the acute treatment of agitation associated with

Atlas H&E-TME is an advanced pathology foundation model developed collaboratively by Mayo Clinic, Charité – Universitätsmedizin Berlin, and Aignostics. Designed to enhance the analysis of hematoxylin and eosin (H&E) stained histopathology images, Atlas H&E-TME leverages a vast dataset of 1.2 million whole slide images from over 490,000 cases. This extensive training enables the model to effectively capture the diverse morphological and technical variations present in pathology, there

Mindpeak Breast Ki-67 HS is an advanced AI-powered software designed for the automated analysis of digital histopathology images of human invasive breast carcinoma tissue samples. It specializes in detecting and quantifying Ki-67, a crucial biomarker associated with cell proliferation, within tumor regions of interest using the hotspot method. This stand-alone module seamlessly integrates into existing laboratory workflows without the need for manual fine-tuning, enhancing diagnostic accuracy an

deepcOS® Hub is a centralized AI management platform designed to streamline radiology operations by providing unified access to a comprehensive suite of tools for radiologists, IT administrators, and AI developers. It integrates seamlessly with existing hospital IT systems, enabling efficient deployment, monitoring, and evaluation of AI solutions within radiology workflows.

Milu Health is a healthcare technology company dedicated to simplifying and reducing the cost of healthcare for employees. By integrating with electronic health records (EHRs), Milu Health's AI-driven platform proactively identifies opportunities for cost savings and improved care quality. This includes assisting patients in finding affordable, high-quality healthcare providers, disputing incorrect medical bills, and accessing more affordable medications. The platform also analyzes employer heal

Zephyr AI is a healthcare technology company dedicated to transforming precision medicine through advanced artificial intelligence and extensive clinicogenomic data. By integrating clinical and molecular patient information with drug structures and targets, Zephyr AI's machine learning models predict drug responses and identify critical gene networks essential for tumor survival. Their platform leverages one of the world's largest clinicogenomic datasets, encompassing over 68 million longitudina

UnityAI is a healthcare technology startup dedicated to transforming hospital operations through advanced artificial intelligence (AI) solutions. By seamlessly integrating AI into existing workflows, UnityAI aims to reduce the operational complexity of healthcare delivery, enabling clinical and administrative staff to focus more on patient care. Founded by experienced data scientists with backgrounds at HCA Healthcare, the company leverages AI to optimize hospital bed management, resource alloca

Ezra offers an AI-powered, end-to-end cancer screening platform designed to detect cancer and over 500 other medical conditions through advanced imaging technologies. By integrating state-of-the-art artificial intelligence with comprehensive MRI scans, Ezra aims to make early cancer detection more accessible, efficient, and affordable.

Ataraxis AI is a pioneering precision medicine company dedicated to transforming cancer diagnostics through advanced artificial intelligence. Their flagship product, Ataraxis Breast, is the world's first AI-native prognostic and predictive platform for breast cancer, offering a 30% improvement in accuracy over traditional genomic assays. By analyzing multi-modal patient data, including standard pathology slides, Ataraxis Breast provides personalized predictions regarding cancer recurrence risk,

Nimblemind.ai is an AI-powered data infrastructure platform designed to help healthcare providers transform unstructured clinical data into structured, AI-ready formats. By curating and enriching multimodal health data, Nimblemind.ai enables organizations to unlock the full potential of their clinical datasets, leading to improved patient outcomes, more efficient administration, and optimized revenue streams.

AZchest is a clinically validated AI radiology solution developed by AZmed, designed to automatically detect and report primary cardiac and pulmonary abnormalities in chest X-rays. Trusted by leading medical institutions worldwide, AZchest enhances diagnostic accuracy and streamlines radiology workflows.

QP-Insights® is an advanced, cloud-based platform designed for the comprehensive management, storage, and analysis of large-scale multi-omics data and medical images. Tailored for clinical studies and research projects, it enables users to enhance their analytical capabilities by integrating imaging data with processed electronic health records (EHR), facilitating the extraction of new predictive models and biomarkers.

PreciseDx is a pioneering company in AI-driven digital pathology, specializing in oncology diagnostics to enhance cancer treatment decisions and patient outcomes. By integrating artificial intelligence with traditional pathology, PreciseDx provides precise, patient-specific risk assessments, enabling more personalized and effective treatment plans.

RwHealth is a healthcare analytics company that leverages artificial intelligence (AI) and machine learning to provide data-driven insights for healthcare and life sciences organizations. Their platform enables clients to optimize care pathways, enhance patient outcomes, and improve operational efficiency. By integrating advanced data science techniques, RwHealth supports decision-making processes across various healthcare sectors, including elective and acute care, mental health, primary care,

Dexa AI is an innovative platform that leverages artificial intelligence to provide users with direct access to expert knowledge from a diverse range of trusted professionals. By indexing and analyzing content from podcasts and videos, Dexa enables users to ask questions and receive precise answers sourced directly from these media, effectively transforming them into dynamic knowledge hubs.

Mindpeak Esophagus PD-L1 is an advanced software solution designed for the automated analysis of digital histopathology images from PD-L1-stained esophageal squamous cell carcinoma tissue samples. This stand-alone application streamlines the detection and quantification of PD-L1 expression, providing pathologists with rapid and accurate tumor proportion scores (TPS). By differentiating between stained (tumor positive) and unstained (tumor negative) cells, the software enhances the precision of i

Mindpeak Prostate H&E is an advanced software module designed for the automated analysis of digital histopathology images of prostate needle biopsies. It identifies areas suspicious for cancer and grades malignancies using the Gleason scoring system. This tool enhances the efficiency and accuracy of prostate cancer detection and grading, providing pathologists with reliable and reproducible results.

deepcOS is a cloud-native radiology AI platform developed by deepc GmbH, designed to seamlessly integrate a diverse range of regulatory-approved AI solutions into existing healthcare IT systems. This vendor-neutral platform enhances radiology workflows by providing clinicians with effortless and secure access to AI-driven diagnostics, thereby improving efficiency and diagnostic confidence at scale.